Imaging identifies breast cancer patients unlikely to benefit from hormone therapy
Hormone therapy commonly is given as a targeted treatment for women whose cancer cells carry receptors for estrogen. But the
Read moreHormone therapy commonly is given as a targeted treatment for women whose cancer cells carry receptors for estrogen. But the
Read moreStructural racism thwarts a large proportion of black patients from receiving appropriate lung cancer care, resulting in worse outcomes and
Read moreTwo presentations from the ADAURA clinical trial advanced previous research that demonstrated improved disease-fee survival (DFS) outcomes for patients with
Read moreThe NRG Oncology and the American College of Radiology Network (ACRIN) multicenter, phase II trial, NRG-RTOG 1106/ACRIN 6697, is the
Read moreA new study finds that older cancer patients are less likely to have optimal results following their cancer operation if
Read morePRINCETON, N.J.–(BUSINESS WIRE) January 22, 2021– Bristol Myers Squibb (NYSE: BMY) today announced that Opdivo (nivolumab) 240 mg (injection for
Read moreUVA Health System, which sues thousands of patients each year, seizing wages and home equity to collect on overdue medical
Read moreOne of the most vexing aspects of the COVID-19 pandemic is doctors’ inability to predict which newly hospitalized patients will
Read moreA new study of liver transplant centers confirms that non-Hispanic white patients get placed on liver transplant waitlists at disproportionately
Read moreTreating critically ill COVID-19 patients with drugs typically used for arthritis may significantly improve survival, a landmark study has found.
Read more